Mercado mundial de anorexígenos: tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado                              

Los anorexígenos son medicamentos que suprimen el apetito y actúan sobre el cerebro. Estimulan el hipotálamo y las partes límbicas del cerebro, que controlan la saciedad. La obesidad se puede tratar con anorexígenos. Según un informe de la Organización Mundial de la Salud, alrededor de 650 millones de personas y 41 millones de niños menores de cinco años eran obesos en todo el mundo en 2017. Algunos de los medicamentos anorexígenos utilizados para tratar la obesidad son lorcaserina ER, naltrexona / bupropión ER, orlistat, liraglutida, lorcaserina y fentermina / topiramato ER. Como la FDA ha autorizado muchos medicamentos para el tratamiento de la obesidad, se espera que el mercado de anorexígenos aumente en los próximos años.

Data Bridge Market Research analiza que el mercado de anorexígenos se valoró en USD 0,82 mil millones en 2021 y se espera que alcance los USD 1,22 mil millones para 2029, registrando una CAGR del 5,12% durante el período de pronóstico de 2022 a 2029. Además de los conocimientos del mercado, como el valor de mercado, la tasa de crecimiento, los segmentos del mercado, la cobertura geográfica, los actores del mercado y el escenario del mercado, el informe de mercado curado por el equipo de Data Bridge Market Research también incluye un análisis de expertos en profundidad, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance del informe y segmentación del mercado

Market Definition

Anorexiants, often known as appetite suppressants, are a type of medication used to treat obesity. This medicine reduces food consumption by acting on the brain to inhibit appetite. Obesity is a long-term condition in which an individual's extra body fat builds up to the point where it threatens his or her health. When people consume more calories than they expend over time, this occurs. Anorexiants are CNS stimulants that reduce appetite and are available as immediate and extended-release tablets. These are prescription medications that should be used in conjunction with a low-calorie diet and regular exercise.

Anorexiants Market Dynamics

Drivers

• Increasing prevalence of obesity

The increasing prevalence of obesity across the globe will fuel industry growth. Obesity is a condition in which a person's body fat levels have accumulated to the point where they are causing health problems. When people consume more calories than they expend over time, this occurs. Obesity raises the risk of chronic diseases such breast cancer, colon cancer, type 2 diabetes, endometrial cancer, cardiovascular disease, and musculoskeletal issues. Obesity afflicted 650 million people and 340 million children and adolescents worldwide in 2016, according to the World Health Organization. This condition can be avoided by changing one's lifestyle. When a person's body mass index (BMI) exceeds 30, that individual is called obese. Inactivity, genetics, family lifestyle, bad nutrition, drugs, age, and pregnancy can all contribute to obesity.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of anorexiants market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Furthermore, surging geriatric population and rise in the number of government initiatives to spread awareness will result in the expansion of anorexiants market. Along with this, sedentary lifestyle of people and increasing level of disposable income will enhance the growth rate of the market. Increasing availability of branded drugs and limited physical inactivity are the factors due to which market is anticipated to grow rapidly during the forecast period of 2022-2029.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the anorexiants market’s growth.

Moreover, the market's growth is fueled by rising technological advancement and emerging new markets. These factors will provide beneficial opportunities for the anorexiants market growth.

Restraints/Challenges

On the other hand, high cost of drug development and distribution will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies and dearth of skilled professionals will challenge the anorexiants market. Additionally, lack of awareness among people and side effects linked with the anorexiants such as diarrhea, tachycardia, headache, myalgia, insomnia, nausea, vomiting and others will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This anorexiants market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the anorexiants market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Anorexiants market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Anorexiants Market

Obese persons have faced difficulties as a result of the COVID-19 shutdown. During this time, the lifestyle was drastically altered: nutrition, activity, and sleep habits, home office, child care, and social isolation. All of these changes could have contributed to tension and anxiety. It has previously been shown that high levels of perceived stress are linked to a predilection for sweet and fatty foods. Binge eating disorder, which is characterized by compulsive overeating or ingesting abnormal amounts of food while feeling unable to stop and a loss of control, has become more common in this situation. Patients with binge eating problems may have been particularly sensitive to the effects of lockdown, necessitating immediate medical attention. Hence, all these factors lead to the high demand of anorexiants market during pandemic period.

Global Anorexiants Market Scope

The anorexiants market is segmented on the basis of indication, drugs class, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Class

• Catecholamines Anorexiants
• Serotonin Anorexiants

Indication

• ADHD
• Dravet Syndrome
• Lennox-Gastaut Syndrome
• Obesity
• Weight Loss
• Others

Route of Administration

• Oral
• Subcutaneous
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Anorexiants Market Regional Analysis/Insights

The anorexiants market is analysed and market size insights and trends are provided by country, indication, drugs class, route of administration, end-users and distribution channel as referenced above.

The countries covered in the anorexiants market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the anorexiants market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the growing prevalence of obesity and rising healthcare expenditure will further propel the market’s growth rate in this region. Additionally, growing presence of major key players and rise in adoption of newer technologies will further propel the market’s growth rate in this region.

Se espera que Asia-Pacífico sea la región de más rápido crecimiento durante el período de pronóstico de 2022 a 2029 debido al aumento del nivel de ingresos disponibles en esta región. Además, el desarrollo de la infraestructura de atención médica y el creciente número de fabricantes de medicamentos genéricos impulsarán aún más la tasa de crecimiento del mercado en esta región.

La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en la regulación en el mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Puntos de datos como análisis de la cadena de valor aguas abajo y aguas arriba, tendencias técnicas y análisis de las cinco fuerzas de Porter, estudios de casos son algunos de los indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas globales y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales se consideran al proporcionar un análisis de pronóstico de los datos del país.   

Análisis del panorama competitivo y de la cuota de mercado de los anorexígenos

El panorama competitivo del mercado de anorexígenos proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento del producto, la amplitud y la variedad del producto, el dominio de la aplicación. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado de anorexígenos.

Algunos de los principales actores que operan en el mercado de anorexígenos son:

• F. Hoffmann-La Roche Ltd. (Suiza)
• Mylan NV (Estados Unidos)
• Teva Pharmaceutical Industries Ltd. (Irlanda)
• Sanofi (Francia)
• Pfizer Inc. (Estados Unidos)
• GlaxoSmithKline plc (Reino Unido)
• Novartis AG (Suiza)
• Merck & Co., Inc. (Estados Unidos)
• AstraZeneca (Reino Unido)
• Johnson & Johnson Private Limited (Estados Unidos)
• Aurobindo Pharma (India)
• Cipla Inc. (Estados Unidos)
• Lannett (Estados Unidos)
• Bausch Health Companies Inc. (Canadá)
• Industrias farmacéuticas Sun Ltd. (India)
• Novo Nordisk A/S (Dinamarca)
• Currax Pharmaceuticals LLC (Estados Unidos)
• Eisai Co., Ltd. (Japón)
• Takeda Pharmaceutical Company Limited (Japón)

SKU-53390